Overview
Papillary carcinoma of the cervix uteri is a very rare type of cancer that develops in the cervix, which is the lower part of the uterus (womb) that connects to the vagina. This specific subtype is characterized by a papillary growth pattern, meaning the cancer cells form finger-like projections when viewed under a microscope. It is important to note that this disease entry has been marked as 'obsolete' in medical classification systems, meaning it may now be classified under a broader or updated category of cervical cancers. Like other cervical cancers, papillary carcinoma of the cervix may cause symptoms such as abnormal vaginal bleeding (especially after intercourse), unusual vaginal discharge, pelvic pain, and pain during sexual intercourse. In early stages, there may be no noticeable symptoms at all, which is why regular cervical screening (such as Pap smears) is so important for early detection. Treatment typically depends on the stage at diagnosis and may include surgery, radiation therapy, chemotherapy, or a combination of these approaches. Because this is a rare subtype, treatment decisions are often guided by the general principles used for other cervical cancers. Outcomes vary depending on how early the cancer is found and how well it responds to treatment. Patients with this diagnosis should be managed by a team of specialists experienced in gynecologic cancers.
Also known as:
Key symptoms:
Abnormal vaginal bleedingBleeding after sexual intercourseUnusual vaginal dischargePelvic painPain during sexual intercourseBleeding between periodsHeavier or longer menstrual periods than usualBleeding after menopauseLower back painUnexplained weight lossFatigueLeg swelling (in advanced cases)
Sporadic
Usually appears on its own, not inherited from a parent
Adult
Begins in adulthood (age 18 or older)
Treatments
No FDA-approved treatments are currently listed for OBSOLETE: Papillary carcinoma of the cervix uteri.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for OBSOLETE: Papillary carcinoma of the cervix uteri at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for OBSOLETE: Papillary carcinoma of the cervix uteri.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to OBSOLETE: Papillary carcinoma of the cervix uteri.
Community
No community posts yet. Be the first to share your experience with OBSOLETE: Papillary carcinoma of the cervix uteri.
Start the conversation →Latest news about OBSOLETE: Papillary carcinoma of the cervix uteri
No recent news articles for OBSOLETE: Papillary carcinoma of the cervix uteri.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Questions for your doctor
Bring these to your next appointment
- Q1.What stage is my cancer, and what does that mean for my treatment options?,Is this papillary subtype treated differently from other types of cervical cancer?,Will my treatment affect my ability to have children in the future?,What side effects should I expect from the recommended treatment?,Are there any clinical trials available for my specific type of cervical cancer?,How often will I need follow-up visits and scans after treatment?,What support services are available to help me cope with the emotional and physical effects of treatment?
Common questions about OBSOLETE: Papillary carcinoma of the cervix uteri
What is OBSOLETE: Papillary carcinoma of the cervix uteri?
Papillary carcinoma of the cervix uteri is a very rare type of cancer that develops in the cervix, which is the lower part of the uterus (womb) that connects to the vagina. This specific subtype is characterized by a papillary growth pattern, meaning the cancer cells form finger-like projections when viewed under a microscope. It is important to note that this disease entry has been marked as 'obsolete' in medical classification systems, meaning it may now be classified under a broader or updated category of cervical cancers. Like other cervical cancers, papillary carcinoma of the cervix may
How is OBSOLETE: Papillary carcinoma of the cervix uteri inherited?
OBSOLETE: Papillary carcinoma of the cervix uteri follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does OBSOLETE: Papillary carcinoma of the cervix uteri typically begin?
Typical onset of OBSOLETE: Papillary carcinoma of the cervix uteri is adult. Age of onset can vary across affected individuals.